Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from Proteomics International Laboratories Ltd. ( (AU:PIQ) ) is now available.
Proteomics International Laboratories Ltd has announced the quotation of 160,420 fully paid ordinary securities on the ASX, effective July 9, 2025. This move is part of the company’s strategy to enhance its market presence and provide more liquidity to its shareholders, potentially impacting its operational capabilities and market positioning positively.
The most recent analyst rating on (AU:PIQ) stock is a Hold with a A$0.43 price target. To see the full list of analyst forecasts on Proteomics International Laboratories Ltd. stock, see the AU:PIQ Stock Forecast page.
More about Proteomics International Laboratories Ltd.
Proteomics International Laboratories Ltd operates in the biotechnology industry, focusing on the development and commercialization of diagnostic tests and analytical services. The company is known for its work in proteomics, which involves the large-scale study of proteins, and it targets markets in healthcare and life sciences.
Average Trading Volume: 247,143
Technical Sentiment Signal: Sell
Current Market Cap: A$69.5M
For detailed information about PIQ stock, go to TipRanks’ Stock Analysis page.